LEADER 04298nam 2200637 a 450 001 9910960776103321 005 20230725031412.0 010 $a9786613239280 010 $a9781283239288 010 $a1283239280 010 $a9781572337947 010 $a157233794X 035 $a(CKB)2670000000092544 035 $a(OCoLC)729256142 035 $a(CaPaEBR)ebrary10471908 035 $a(SSID)ssj0000520892 035 $a(PQKBManifestationID)11337639 035 $a(PQKBTitleCode)TC0000520892 035 $a(PQKBWorkID)10514909 035 $a(PQKB)10941862 035 $a(MiAaPQ)EBC692529 035 $a(OCoLC)726734871 035 $a(MdBmJHUP)muse14662 035 $a(Au-PeEL)EBL692529 035 $a(CaPaEBR)ebr10471908 035 $a(CaONFJC)MIL323928 035 $a(Perlego)4876282 035 $a(EXLCZ)992670000000092544 100 $a20101029d2011 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aAndrew Johnson's Civil War and reconstruction /$fPaul H. Bergeron 205 $a1st ed. 210 $aKnoxville $cUniversity of Tennessee Press$d2011 215 $a1 online resource (313 p.) 300 $aBibliographic Level Mode of Issuance: Monograph 311 08$a9781572337480 311 08$a1572337486 320 $aIncludes bibliographical references and index. 330 8 $aFew figures in American political history are as reviled as Andrew Johnson, the seventeenth president of the United States. Taking office after the assassination of Abraham Lincoln, he clashed constantly with Congress during the tumultuous early years of Reconstruction. He opposed federally-mandated black suffrage and the Fourteenth Amendment and vetoed the Freedmen's Bureau and Civil Rights bills. In this new book, Paul H. Bergeron, a respected Johnson scholar, brings a new perspective on this often vilified figure. Previous books have judged Johnson out of the context of his times or through a partisan lens. But this volume-based on Bergeron's work as the editor of The Papers of Andrew Johnson-takes a more balanced approach to Johnson and his career. Admiring Johnson's unswerving devotion to the Union, Lincoln appointed him as military governor of Tennessee, a post, Bergeron argues, that enhanced Johnson's executive experience and his national stature. While governor, Johnson implemented the emancipation of slaves in the state and laid the foundation for a new civilian government. Bergeron also notes that Johnson developed a close connection with the president which eventually resulted in his vice-presidential candidacy. In many respects, therefore, Johnson's Civil War years served as preparation for his presidency. Bergeron moves beyond simplistic arguments based on Johnson's racism to place his presidency within the politics of the day. Putting aside earlier analyses of the conflict between Johnson and the Republican Radicals as ideological disputes, Bergeron discusses these battles as a political power struggle. In doing so, he does not deny Johnson's racism but provides a more nuanced and effective perspective on the issues as Johnson tried to pursue the "politics of the possible." Bergeron interprets Johnson as a strong-willed, decisive, fearless, authoritarian leader in the tradition of Andrew Jackson. While never excusing Johnson's inflexibility and extreme racism, Bergeron makes the case that, in proper context, Johnson can be seen at times as a surprisingly effective commander-in-chief-one whose approach to the problems of reestablishing the Union was defensible and consistent. With its fresh insight on the man and his times, Andrew Johnson's Civil War and Reconstruction is indispensable reading for students and scholars of the U.S. presidency and the Civil War and Reconstruction periods. 606 $aPresidents$zUnited States$vBiography 607 $aUnited States$xPolitics and government$y1849-1877 615 0$aPresidents 676 $a973.8/1092 676 $aB 700 $aBergeron$b Paul H.$f1938-$01699284 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910960776103321 996 $aAndrew Johnson's Civil War and reconstruction$94353367 997 $aUNINA LEADER 00981nam a2200265/i 4500 001 991003349959707536 005 20250529144453.0 008 981223s19950000it 001 | ita 035 $ab14320502-39ule_inst 040 $aBibl. Dip.le Aggr. Scienze Economia - Sez. Settore Economico$bita 245 00$aContabilità e bilancio d'esercizio /$cM. Campra, V. Cantino 250 $a4. ed 260 $aMilano :$bGiuffrè,$c1995 300 $a2 v. ;$c24 cm 490 0 $aManuali di formazione e di consultazione professionale 650 04$aBilancio 650 04$aContabilità 700 1 $aCantino, Valter 700 1 $aCampra, Maura 907 $a.b14320502$b05-04-19$c27-03-17 912 $a991003349959707536 945 $aLE025 ECO 657 CAM01.01$cV. 2$g1$i2025000277809$lle025$nCatalogato 2017$o-$pE45.00$q-$rl$s-$t0$u0$v0$w0$x0$y.i1580091x$z27-03-17 996 $aContabilità e bilancio d'esercizio$962626 997 $aUNISALENTO 998 $ale025$b27-03-17$cm$da$fita$git$h0$i0 LEADER 02855oas 2201189 a 450 001 9910146885503321 005 20251105213014.0 011 $a1476-5500 035 $a(DE-599)ZDB2004200-0 035 $a(OCoLC)42895504 035 $a(CONSER) 2008242167 035 $a(CKB)954925568785 035 $a(EXLCZ)99954925568785 100 $a19991129a19949999 sy 101 0 $aeng 135 $aurmnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aCancer gene therapy 210 $a[Houndmills, Basingstoke, Hampshire, UK] $cStockton Press 215 $a1 online resource 300 $aRefereed/Peer-reviewed 311 08$a0929-1903 606 $aCancer$xGene therapy$vPeriodicals 606 $aGene therapy$vPeriodicals 606 $aGenetic Therapy 606 $aNeoplasms$xtherapy 606 $aCancer$xThe?rapie ge?nique$vPe?riodiques 606 $aThe?rapie ge?nique$vPe?riodiques 606 $aThe?rapie ge?nique 606 $aGenetics & Genomics$2ebps 606 $aOncology$2ebps 606 $aCancer$xGene therapy$2fast$3(OCoLC)fst00845367 606 $aGene therapy$2fast$3(OCoLC)fst00939638 608 $aPeriodical. 608 $aperiodicals.$2aat 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 608 $aPe?riodiques.$2rvmgf 615 0$aCancer$xGene therapy 615 0$aGene therapy 615 2$aGenetic Therapy. 615 2$aNeoplasms$xtherapy. 615 6$aCancer$xThe?rapie ge?nique 615 6$aThe?rapie ge?nique 615 6$aThe?rapie ge?nique. 615 7$aGenetics & Genomics. 615 7$aOncology. 615 7$aCancer$xGene therapy. 615 7$aGene therapy. 676 $a616.99406 801 0$bF#A 801 1$bF#A 801 2$bOCLCQ 801 2$bMXC 801 2$bOCLCQ 801 2$bHUA 801 2$bOCLCQ 801 2$bDLC 801 2$bMYG 801 2$bOCLCQ 801 2$bTEU 801 2$bUKMGB 801 2$bOCLCQ 801 2$bOCLCF 801 2$bOCLCQ 801 2$bSCB 801 2$bOCLCO 801 2$bOCLCA 801 2$bWT2 801 2$bOCLCQ 801 2$bOCLCO 801 2$bOCLCQ 801 2$bOCLCA 801 2$bU3W 801 2$bOCLCQ 801 2$bOCLCO 801 2$bAU@ 801 2$bOCLCO 801 2$bWYU 801 2$bOCLCO 801 2$bOCLCA 801 2$bVT2 801 2$bOCLCO 801 2$bSFB 801 2$bOCLCQ 801 2$bOCLCO 801 2$bLDP 801 2$bCNMTR 801 2$bSRU 801 2$bOCLCQ 801 2$bOCLCL 801 2$bCSU 801 2$bLIP 801 2$bXFH 801 2$bUWO 801 2$bOCLCQ 906 $aJOURNAL 912 $a9910146885503321 996 $aCancer gene therapy$9796651 997 $aUNINA